43°
The Food and Drug Administration's scientific advisory committee held daylong discussions on Friday, Sept. 17 after which it determined that those who are age 65 or older or are at high risk of severe COVID should get booster shots.
Earlier, the panel announced it had overwhelmingly voted against approving a Pfizer/BioNTech booster for all people 16 and older. The vote was 16-2.
The FDA typically follows the determinations of the panel.
A group of leading scientists said in a paper published this week that available data showed vaccine protection against severe disease persists over time.
“Current evidence does not, therefore, appear to show a need for boosting in the general population, in which efficacy against severe disease remains high,” the scientists wrote."
Check back to Daily Voice for updates.
Click here to follow Daily Voice Amherst and receive free news updates.
